Immix Biopharma (IMMX) Financial Statements

Immix Biopharma's market cap is currently $186.69M. The company's EPS TTM is $-0.723; its P/E ratio is ―; Immix Biopharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.